Combination Chemotherapy for the Treatment of Indian Kala-Azar
NCT00370825
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Visceral Leishmaniasis
Interventions
DRUG:
Combination therapy with AmBisome and miltefosine
Sponsor
Banaras Hindu University